Eficacia y seguridad de pembrolizumab más lenvatinib en participantes con tumores sólidos seleccionados tratados previamente
The purpose of this study is to determine the safety and efficacy of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/MK-7902) in participants with triple negative breast cancer (TNBC), ovarian cancer,